SEEGENE, INC.

Location not on file

OncologyvaccineGrant-only

What changed

Study registered, no phase assigned: Reduced Vaccine Response to HZ/su in SLE

5w agoTrial registeredJun 9, 2026Source filing (opens the source filing in a new tab)

Momentum

74no change

Accelerating: several high-weight events landed recently.

Runway (estimate)

—unknown

No disclosed raise on file, so there is nothing to model from.

Stage

Grant-only

The furthest-along thing in the public record. Not a projection.

Runway is an estimate: the last disclosed raise (SEC Form D) minus a modeled burn rate for the company’s stage and therapeutic area. It is not a disclosure, and companies routinely raise non-dilutive money we can’t see. How this is calculated.

Grant to raise

Every record Biodatica has resolved onto this company, newest first, each linked to the filing it came from. Where a source publishes no stable deep link for a record, the identifier is shown so you can look it up yourself.

Trial
NA registered
May 12, 2025
Thyroid Cancer, Papillary Thyroid Carcinoma · NOT_YET_RECRUITING · sponsor: National Cancer Center, Korea · Shared Decision-Making for Determining Treatment Strategies in Low-Risk Thyroid Cancer
ClinicalTrials.gov · NCT06730893 (opens the source filing in a new tab)
Patent
Patent granted
Jan 7, 2025
assignee: SEEGENE, INC. · Method And Apparatus For Detecting A Plurality Of Target Nucleic Acid Sequences In Sample
USPTO · US 12188082 (opens the source filing in a new tab)
Trial
Study registered
Oct 1, 2024
Vaccine Reaction, Zoster, Systemic Lupus Erythematosus · RECRUITING · sponsor: Seoul National University Hospital · Reduced Vaccine Response to HZ/su in SLE
ClinicalTrials.gov · NCT07636044 (opens the source filing in a new tab)
Grant
R33 · $80k · non-dilutive
Sep 1, 2022
PURDUE UNIVERSITY · PI KIM, YOUNG L · FIC · award ends May 31, 2027 · Risk stratification of malaria among school-age children with mHealth spectroscopy of blood analysis
NIH RePORTER · NIH RePORTER 11381358 (opens the source filing in a new tab)
Grant
R33 · $177k · non-dilutive
Sep 1, 2022
PURDUE UNIVERSITY · PI KIM, YOUNG L · FIC · award ends May 31, 2027 · Risk stratification of malaria among school-age children with mHealth spectroscopy of blood analysis
NIH RePORTER · NIH RePORTER 11142441 (opens the source filing in a new tab)
Patent
Patent assigned
Sep 29, 2020
assignee: SEEGENE, INC. · Method And Apparatus For Detecting A Plurality Of Target Nucleic Acid Sequences In Sample
USPTO · US 12188082 (opens the source filing in a new tab)

How this crosswalk was built

Confidence 100%Edges merged automatically, not yet reviewed by a human

Shared principal investigator or founder links the trial record at 0.75{"reasons":["grant to an academic institution linked by a shared principal investigator"]}
Shared principal investigator or founder links the trial record at 0.75{"reasons":["grant to an academic institution linked by a shared principal investigator"]}
Shared principal investigator or founder links the grant record at 0.75{"reasons":["grant to an academic institution linked by a shared principal investigator"]}
Shared principal investigator or founder links the grant record at 0.75{"reasons":["grant to an academic institution linked by a shared principal investigator"]}
Shared principal investigator or founder links the patent record at 0.70{"reasons":["name similarity 100%","shared principal investigator / founder"]}
new_entity links the patent record at 0.22{"reasons":["no candidate cleared the review threshold"]}

Links score at or above 0.86 to merge automatically. Anything below that and above the review line goes to a human queue. Resolution is a judgment, and it can be wrong. How resolution works.

Event stream

Every scored event, newest first. This is what momentum is computed from.

Study registered, no phase assigned: Reduced Vaccine Response to HZ/su in SLE
5w agoTrial registeredSource (opens the source filing in a new tab)
Trial now recruiting: Reduced Vaccine Response to HZ/su in SLE
5w agoTrial recruitingSource (opens the source filing in a new tab)
NIH R33 · $0.1M · Risk stratification of malaria among school-age children with mHealth spectroscopy of blood analysis
11mo agoGrant renewalSource (opens the source filing in a new tab)
NIH R33 · $0.2M · Risk stratification of malaria among school-age children with mHealth spectroscopy of blood analysis
11mo agoGrant renewalSource (opens the source filing in a new tab)
Study registered, no phase assigned: Shared Decision-Making for Determining Treatment Strategies in Low-Risk Thyroid Cancer
Apr 2025Trial registeredSource (opens the source filing in a new tab)
Patent granted · Method And Apparatus For Detecting A Plurality Of Target Nucleic Acid Sequences In Sample
Jan 2025Patent grantedSource (opens the source filing in a new tab)
Patent assigned · Method And Apparatus For Detecting A Plurality Of Target Nucleic Acid Sequences In Sample
Sep 2020Patent assignedSource (opens the source filing in a new tab)

Last disclosed raise

No Form D is on file, so there is no raise to model a runway from. That is why the runway reads “—” rather than a number. It does not mean the company has no money: grants, revenue and notes below the Form D threshold are all invisible here.

Something wrong on this page? The crosswalk is a judgment and we would rather hear it. Report a bad link.

Biodatica publishes impersonal research shown identically to every subscriber. This dossier is informational only, it is not investment advice, and the momentum and runway figures are estimates derived from public filings. The underlying records are U.S. government works. Disclosures · Data sources

Grant to raise

NA registered

Patent granted

Study registered

R33 · $80k · non-dilutive

R33 · $177k · non-dilutive

Patent assigned